Cargando…

THrombolysis for Acute Wake-up and unclear-onset Strokes with alteplase at 0·6 mg/kg (THAWS) Trial

RATIONALE: Because of lack of information regarding timing of stroke, patients who suffer stroke during sleep are generally ineligible for intravenous thrombolysis, although many of these patients could potentially recover with this treatment. Magnetic resonance image findings with positive diffusio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koga, Masatoshi, Toyoda, Kazunori, Kimura, Kazumi, Yamamoto, Haruko, Sasaki, Makoto, Hamasaki, Toshimitsu, Kitazono, Takanari, Aoki, Junya, Seki, Kenta, Homma, Kazunari, Sato, Shoichiro, Minematsu, Kazuo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2014
Materias:	Protocols
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4660886/ https://www.ncbi.nlm.nih.gov/pubmed/25088843 http://dx.doi.org/10.1111/ijs.12360

Ejemplares similares

Intravenous Alteplase at 0.6 mg/kg for Unknown Onset Stroke with Prior Antithrombotic Medication: THAWS Randomized Clinical Trial
por: Koga, Masatoshi, et al.
Publicado: (2023)

Thrombolysis With Alteplase at 0.6 mg/kg for Stroke With Unknown Time of Onset: A Randomized Controlled Trial
por: Koga, Masatoshi, et al.
Publicado: (2020)

Intravenous Thrombolysis With Alteplase at 0.6 mg/kg in Patients With Ischemic Stroke Taking Direct Oral Anticoagulants
por: Okada, Takashi, et al.
Publicado: (2022)

Uric acid enhances alteplase-mediated thrombolysis as an antioxidant
por: Kikuchi, Kiyoshi, et al.
Publicado: (2018)

Intravenous thrombolysis with alteplase in the treatment of acute cerebral infarction
por: Gao, Lilin, et al.
Publicado: (2022)

Stability of alteplase for ultrasound-facilitated catheter-directed thrombolysis
por: Fanikos, John, et al.
Publicado: (2021)

Alteplase or tenecteplase for thrombolysis in ischemic stroke: An illustrated review
por: Zhu, Annie, et al.
Publicado: (2022)

Silver Jubilee of Stroke Thrombolysis With Alteplase: Evolution of the Therapeutic Window
por: Pan, Yuanmei, et al.
Publicado: (2021)

Effect of Apixaban Pretreatment on Alteplase-Induced Thrombolysis: An In Vitro Study
por: Thalerová, Sandra, et al.
Publicado: (2021)

Intravenous thrombolysis for acute ischemic stroke: From alteplase to tenecteplase
por: Yang, Nan, et al.
Publicado: (2023)

Risk Factors for Early Intracerebral Hemorrhage after Intravenous Thrombolysis with Alteplase
por: Lin, Xianda, et al.
Publicado: (2020)

Edaravone, a Synthetic Free Radical Scavenger, Enhances Alteplase-Mediated Thrombolysis
por: Kikuchi, Kiyoshi, et al.
Publicado: (2017)

Using alteplase nephrostomy tube installation for thrombolysis of ureter tract clot obstruction
por: Lin, Paoyan, et al.
Publicado: (2021)

Effect of Alteplase Thrombolysis on Coagulation Function and Nerve Function of Patients with Ischemic Stroke
por: Zhao, Hong-Ying, et al.
Publicado: (2022)

Early changes in fibrinogen after administration of alteplase are associated with the short-term efficacy of thrombolysis
por: Lu, Tao, et al.
Publicado: (2018)

Determinants of 1-Year Unfavorable Outcomes of Intravenous Alteplase Thrombolysis for Acute Ischemic Stroke
por: Zhai, Mingfeng, et al.
Publicado: (2023)

A Comparative Study of Hemorrhagic Conversion Patterns After Stroke Thrombolysis With Alteplase Versus Tenecteplase
por: Ezzeldin, Mohamad, et al.
Publicado: (2023)

Bolus-Infusion Delays of Alteplase during Thrombolysis in Acute Ischaemic Stroke and Functional Outcome at 3 Months
por: Acheampong, Paul, et al.
Publicado: (2014)

Efficacy and safety of low dose alteplase for intravenous thrombolysis in Asian stroke patients: a meta-analysis
por: Tan, Ge, et al.
Publicado: (2017)

Predictors of Postthrombolysis Outcome and Symptomatic Postthrombolysis Hemorrhage following Intravenous Thrombolysis with Alteplase for Acute Ischemic Stroke
por: Das, Suman, et al.
Publicado: (2020)

Tenecteplase and Alteplase for Thrombolysis of Acute Ischemic Stroke within 4.5 Hours: An Efficacy and Safety Study
por: Dhar, Nikita, et al.
Publicado: (2022)

The Reason is Still Unclear
por: Ogura, Masatsune
Publicado: (2022)

Alteplase for acute ischemic stroke: 2 years in a community hospital without previous experience in stroke thrombolysis
por: Estella, A, et al.
Publicado: (2008)

Spontaneous Splenic Rupture Following Intravenous Thrombolysis with Alteplase Applied as Stroke Therapy – Case Report and Review of Literature
por: Aleksic-Shihabi, Anka, et al.
Publicado: (2016)

A case of intra-arterial thrombolysis with alteplase in a patient with hypothenar hammer syndrome but without underlying aneurysm
por: Shukla, Harshal, et al.
Publicado: (2018)

Effects of intravenous thrombolysis with alteplase combined with edaravone on cerebral hemodynamics and T lymphocyte level in patients with acute cerebral infarction
por: Li, Xiu-Xiu, et al.
Publicado: (2020)

Effect of intravenous thrombolysis with alteplase on clinical efficacy, inflammatory factors, and neurological function in patients with acute cerebral infarction
por: Wang, Jinhua, et al.
Publicado: (2021)

Urokinase versus Alteplase in Patients with Intermediate–High-Risk Pulmonary Embolism Treated with Ultrasound-Accelerated Endovascular Thrombolysis
por: Al-Terki, Hani, et al.
Publicado: (2023)

Effect of admission serum glucose on the clinical prognosis of patients with acute ischemic stroke receiving alteplase intravenous thrombolysis
por: Huang, Pan, et al.
Publicado: (2023)

An unclear, chronic nasal ulcer
por: Talhari, Carolina, et al.
Publicado: (2011)

Different doses of tenecteplase vs alteplase in thrombolysis therapy of acute ischemic stroke: evidence from randomized controlled trials
por: Xu, Na, et al.
Publicado: (2018)

Thrombolysis with alteplase 3–4.5 hours after acute ischaemic stroke: trial reanalysis adjusted for baseline imbalances
por: Alper, Brian Scott, et al.
Publicado: (2020)

Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials
por: Emberson, Jonathan, et al.
Publicado: (2014)

Consensus Guides on Stroke Thrombolysis for Anticoagulated Patients from Japan: Application to Other Populations
por: Toyoda, Kazunori, et al.
Publicado: (2018)

Thrombolysis with alteplase 3–4.5 hours after acute ischaemic stroke: the first multicentre, phase III trial in China
por: Zheng, Huaguang, et al.
Publicado: (2020)

Ginkgolide With Intravenous Alteplase Thrombolysis in Acute Ischemic Stroke Improving Neurological Function: A Multicenter, Cluster-Randomized Trial (GIANT)
por: Zhang, Xuting, et al.
Publicado: (2021)

Impact of poly-arginine peptides R18D and R18 on alteplase and tenecteplase thrombolysis in vitro, and neuroprotective stability to proteolysis
por: Meloni, Bruno P., et al.
Publicado: (2022)

Commentary: Surgery postponed, reason unclear
por: Bichell, David P.
Publicado: (2021)

Severe, Complicated Pancreatitis With an Unclear Etiology
por: Nohomovich, Brian, et al.
Publicado: (2023)

Successful treatment of ischemic stroke associated with brachiocephalic artery stenosis using alteplase
por: Mitani, Yuta, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8jlpo021iri8cok5n9sejavkti